Watch Ticker

Pasithea Therapeutics Corp. Common Stock

Go to Pasithea Therapeutics Corp. Common Stock Website

$6.92

(%)

Live

Previous Close

$6.92

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$7.2 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuros...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Pasithea - Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients

Pasithea's IND for PAS-004, a novel MEK inhibitor, is FDA-approved for Phase 1 trials in advanced cancer, starting Q1 2024 with early results by Q3.

Related tickers: KTTA, KTTAW.

Read Full Article

Pasithea - Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023

Pasithea Therapeutics (Nasdaq: KTTA) adjourns stockholder meeting again to Dec 29 for voting on charter amendments, after partial adjournment on Dec 19.

Related tickers: KTTA, KTTAW.

Read Full Article

Trending Tickers

LASE

XNAS

$2.06

(%)

PACW

XNAS

$7.54

(%)

SMFL

XNAS

$3.32

(%)

SQ

XNYS

$70.30

(%)

MLGO

XNAS

$0.00

(%)